Skip to main content

Table 3 Clinical characterestics, co-morbidities and medications in HFrEF and HFpEF subgroups

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

 HFrEF, n = 73HFpEF, n = 45P value
Age (years)66.9 ± 952.3 ± 110.0001
Chest pain (CP)22 (30%)1 (2.22%)0.001
Killip class   
 I7 (9.6%)4 (9%)0.935
 II4 (5.5%)2 (4.44%)0.915
 III16 (22%)11 (24.44%)0.887
 IV44 (60.3%)27 (60%)0.941
Orthopnea50 (68.5%)30 (66.67%)0.932
PND12 (16.4%)4 (9%)0.488
Palpitations3 (4.12%)11 (24.44%)0.004
Syncope1 (1.4%)0 (0%)0.692
Cough dry3 (4.12%)5 (11.11%)0.142
Productive cough19 (26%)11 (24.44%)0.339
Edema26 (35.6%)12 (26.67%)0.256
Previous MI13 (17.8%)6 (13.33%)0.500
Previous PCI9 (12.3%)3(6.67%)0.380
Previous CABG7 (9.6%)1(2.22%)0.190
Valve surgery1 (1.4%)5(11.11%)0.035
STEMI16 (21.9%)0 (0%)0.002
STEMI16 (21.9%)0 (0%)0.002
UA/NSTEMI8 (11%)13(28.9%)0.000
CHB1 (1.34%)0 (0%)0.436
AF/flutter10 (13.7%)12 (26.6%)0.039
IE0 (0%)1 (2.2%)0.077
PE1 (1.34%)2 (4.44%)0.303
Aortic dissection1 (1.34%)2 (4.44%)0.303
Hypertension4(5.5%)11(24.44%)0.000
Prior HF20 ( 27%)8 (17.78%)0.000
RHD0 (0%)4 (8.89%)0.000
Pacemaker1 (1.4%)2 (4.44%)0.108
ICD1 (1.4%)0 (0%)0.436
CVP52 (71.2%)19 (42.2%)0.002
Endotracheal intubation15 (20.5%)0 (0%)0.001
Thazides22 (12.4%)8 (6.8%)0.119
Loop diuretics109 (61%)68 (57.6%)0.535
Nitrates103 (58%)67 (56.78%)0.853
Warfarin63 (35.4%)31 (26.3%)0.099
Clopedogril75 (42.1%)58 (49.2%)0.235
Hospital stay7.88 ± 5.75.73 ± 3.40.02
Sepsis1 (1.4%)2 (4.4%)0.303
Pneumonia4 (5.5%)2 (4.44%)0.575
Fever0 (0%)1 (2.22%)0.172
Hemoptesis1 (1.4%)0 (0.85%) 
Lanoxin toxicisty0 (0%)
0 (0%)
1 (2.22%)
1 (2.22%)
 
CKD/ESRD3 (4.12%)0 (0%)0.236
Respiratory failure2 (2.7%)2 (4.44%)0.511
liver failure3 (4.12%)6 (13.3%)0.067
Tamponade1 (1.4%)2 (4.44%)0.303
GIT bleeding1 (1.4%)2 (4.44%)0.303
CCI71 (97.3%)41 (91%)0.140
Previous MI13 (17.8%)4 (4.44%)0.261
AKI12 (16.4%)0 (0%)0.016
PVD1 (1.4%)1 (2.22%)0.549
CVA/TIA7 (9.6%)3 (6.7%)0.518
Hemiplegia2 (2.7%)0 (0%)0.322
COPD7 (9.6%)3 (6.67%)0.056
Autoimmune8 (11%)0 (0%)0.046
Mild liver diseases1 (1.4%)0 (0%)0.436
peptic ulcer0 (0%)1 (2.22%)0.254
Cancer1 (1.4%)0 (0%)0.436
Metasis1 (1.4%)2 (4.4%)0.303
Dementia1 (1.4%)2 (4.44%)0.336
Rheumatic D1 (1.4%)2 (4.4%)0.303
HIV0 (0%)1 (2.22%)0.254
Cellulitis3 (4.12%)6 (13.%)0.067
Depression0 (0%)2 (4.4%)0.108
Mechanical ventilation14 (19.2%)1 (2.22%)0.007
Pricardiocentesis0 (0%)1 (2.22%)0.201
PCI7 (9.6%)0 (0%)0.032
Coronary angiography5 (6.8%)0 (0%)0.073
Amiodarone17 (9.6%)7 (14.4%)0.200
Unfractunated heparin62 (34.8%)34(28.8%)0.279
LMWH100 (56.2%)79 (67%)0.064
Lytic therapy45 (25.3%)32 (27.1%)0.724
Mortality12 (16.4%)1 (2.22%)0.01
  1. BMI body mass index, DM diabetes mellitus, HTN hypertension, STEMI ST segment elevation myocardial infarction, UA unstable angina, IE infective endocarditis, PE pulmonary embolism, CHB complete heart block, Af atrial flutter, AF atrial fibrillation, PCI percutaneous coronary intervention, CA coronary angiography, CVA cerebrovascular accident, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure